STEFANIC; Martin Friedrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for STEFANIC; Martin Friedrich.The latest application filed is for "pharmaceutical combination".

Company Profile

0.0.14

STEFANIC; Martin Friedrich - Warthausen DE
STEFANIC; Martin Friedrich - Warthausen-Birkenhard DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Combination App 20180243308 - STEFANIC; Martin Friedrich ; et al.	2018-08-30
Pharmaceutical Combination App 20160250218 - STEFANIC; Martin Friedrich ; et al.	2016-09-01
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20150265610 - STEFANIC; Martin Friedrich ; et al.	2015-09-24
Pharmaceutical combination App 20150174126 - STEFANIC; Martin Friedrich ; et al.	2015-06-25
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20140057898 - STEFANIC; Martin Friedrich ; et al.	2014-02-27
Pharmaceutical combination App 20130237549 - STEFANIC; Martin Friedrich ; et al.	2013-09-12
Pharmaceutical combination App 20110178099 - Stefanic; Martin Friedrich ; et al.	2011-07-21
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20110171289 - STEFANIC; Martin Friedrich ; et al.	2011-07-14
Use of Lck inhibitors for treatment of immunologic diseases App 20090087405 - ROTH; Gerald Juergen ; et al.	2009-04-02
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells Or Angiogenesis App 20080254040 - STEFANIC; Martin Friedrich ; et al.	2008-10-16
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis App 20050043233 - Stefanic, Martin Friedrich ; et al.	2005-02-24
Use of Lck inhibitors for treatment of immunologic diseases App 20040204458 - Roth, Gerald Juergen ; et al.	2004-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.